BP734

氨甲环酸杂质标准品

British Pharmacopoeia (BP) Reference Standard

• 别名: 反-4-(氨基甲基)环己烷羧酸, AMCA, 反-4-(氨基甲基)环已基羧酸, 抗血纤溶环酸, 氨甲基环己酸, 氨甲环酸
• 线性分子式: H₂NCH₂C₆H₁₀CO₂H
• CAS号: 1197-18-8
• 分子量: 157.21
• Beilstein: 2207452
• MDL编号: MFCD00001466
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 等级: pharmaceutical primary standard
• API类: tranexamic acid
• 表单: crystalline
• 保质期: limited shelf life, expiry date on the label
• 制造商/商品名称: BP
• mp: >300 °C (lit.)
• 应用: pharmaceutical; pharmaceutical small molecule
• 包装形式: mixture
• 储存温度: 2-8°C
• SMILES字符串: NC[C@H]1CC[C@@H](CC1)C(O)=O
• InChI: 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7-
• InChI key: GYDJEQRTZSCIOI-LJGSYFOKSA-N
• 基因信息: human ... PLG(5340)

说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Tranexamic acid impurity standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Tranexamic Acid Injection

Tranexamic Acid Tablets

包装

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

安全信息

• 象形图: GHS07
• 警示用语：: Warning
• 危险声明: H315,H319,H335
• 预防措施声明: P302 + P352 - P305 + P351 + P338
• 危险分类: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 靶器官: Respiratory system
• 储存分类代码: 11 - Combustible Solids
• WGK: WGK 2
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable